Halina S. White

Neurology
520 E 70th St # 607
New York, NY 10021

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development.

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development.

Journal: Epilepsia
Published: May 07, 2026

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development.

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development.

Journal: Epilepsia
Published: May 07, 2026

The Discovery of Cenobamate: A Drug with High Efficacy in Drug-Resistant Epilepsy.

The Discovery of Cenobamate: A Drug with High Efficacy in Drug-Resistant Epilepsy.

Journal: CNS drugs
Published: November 15, 2025

Studies on the anticonvulsant potential of 6-gingerol, an active ingredient of ginger rhizome.

Studies on the anticonvulsant potential of 6-gingerol, an active ingredient of ginger rhizome.

Journal: Frontiers in pharmacology
Published: November 05, 2025

The Complexity and Challenges of Developing Effective Epilepsy Therapies: Lessons to be Learned from Comparing Cenobamate, Carisbamate, and Padsevonil.

The Complexity and Challenges of Developing Effective Epilepsy Therapies: Lessons to be Learned from Comparing Cenobamate, Carisbamate, and Padsevonil.

Journal: CNS drugs
Published: September 11, 2025

Potential for Therapeutic Alteration of the Underlying Biology of Epilepsy.

Potential for Therapeutic Alteration of the Underlying Biology of Epilepsy.

Journal: Biomedicines
Published: July 09, 2025

Preclinical signal for a disease-modifying effect on seizure cluster severity with intermittent diazepam treatment.

Preclinical signal for a disease-modifying effect on seizure cluster severity with intermittent diazepam treatment.

Journal: Epilepsia
Published: July 01, 2025

PAC-FOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures.

PAC-FOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures.

Journal: Epilepsia
Published: April 16, 2025

Aspirin does not modify cardiovascular event risk in endometriosis in the California Teachers Study.

Aspirin does not modify cardiovascular event risk in endometriosis in the California Teachers Study.

Journal: European heart journal open
Published: January 21, 2025

Challenging the preclinical paradigm: Adverse effects of antiseizure medicines in male rats with drug-resistant epilepsy.

Challenging the preclinical paradigm: Adverse effects of antiseizure medicines in male rats with drug-resistant epilepsy.

Journal: British journal of pharmacology
Published: December 10, 2024

Rates of Acute Brain Injury Among Severely Hypertensive Patients Seen in the Emergency Department.

Rates of Acute Brain Injury Among Severely Hypertensive Patients Seen in the Emergency Department.

Journal: The Neurohospitalist
Published: September 23, 2024

ENX-101, a GABAA receptor α2,3,5-selective positive allosteric modulator, displays antiseizure effects in rodent seizure and epilepsy models.

ENX-101, a GABAA receptor α2,3,5-selective positive allosteric modulator, displays antiseizure effects in rodent seizure and epilepsy models.

Journal: Epilepsia
Published: September 17, 2024
Showing 1-12 of 121

Last Updated: 09/26/2026